What's hot

View all perspectives
What's Hot

What's new in sarcoidosis?

Watch video →

Rheumatoid Arthritis Comorbidities

Dr. Jonathan Kay reviews rheumatoid arthritis studies presented on day at EULAR 2022. Specifically, he discusses abstracts OP0132, OP0135 and OP0138.

Watch video →

Increasing Secukinumab Dose in Ankylosing Spondylitis Nonresponders

  Dr. Peter Nash discusses abstract OP0023 from EULAR 2022.

Watch video →

DMARDS, Prednisone, Pregnancy, OH MY!

Dr. Kathryn Dao discusses abstracts POS1405, POS0696 and OP0130 presented at the EULAR 2022 meeting. Watch more videos from EULAR 2022 here: https://rheumnow.com/videos. 

Watch video →

Sarcopenia

Watch video →

Breathing New Insight into RA Interstitial Lung Disease

Dr. Jonathan Kay reviews EULAR 2022 abstracts OP0132, OP0306, and OP0307.

Watch video →

EULAR 2022 - Day 4 Faculty Panel Recap

Dr. David Liew and Dr. Jack Cush discuss day 4 of EULAR 2022. LB0001, LB0002, LB0004, and LB0006.

Watch video →

Getting to the Heart of JAK Inhibitors

Dr. Jonathan Kay reviews rheumatoid arthritis sessions and abstracts from day 3 at EULAR 2022. Abstracts reviewed: OP0266; OP0258; and OP0269. 

Watch video →

EULAR 2022 - Day 3 Faculty Panel Recap

Drs. Jack Cush, Janet Pope, Aurelie Najm and Yuz Yusof discuss highlights from Day 3 of EULAR 2022.

Watch video →

Deucravacitinib at EULAR 2022

Dr. Peter Nash provides and update on the TYK2 inhibitor, Deucravacitinib with reports on: - Safety of Deucravacitinib https://bit.ly/3NtZQxe - Deucravacitinib in SLE https://bit.ly/3Mh5nG0

Watch video →
      RT @KDAO2011: Prof T Dorner summarizes what's new in #SLE #EULAR2022
      @rheumnow https://t.co/YT0Ocw7I41

      TheDaoIndex KDAO2011

      3 years 6 months ago
      Prof T Dorner summarizes what's new in #SLE #EULAR2022 @rheumnow https://t.co/YT0Ocw7I41
      RT @RichardPAConway: Large collaborative study on IIM treatment patterns from @Nellziade @ElenaNikiUK @LatikaGupta_ @drh

      Richard Conway RichardPAConway

      3 years 6 months ago
      Large collaborative study on IIM treatment patterns from @Nellziade @ElenaNikiUK @LatikaGupta_ @drhectorchinoy @MarcinMilchert and many others. Significant geographic differences, highlighting need for consensus guidelines @RheumNow #EULAR2022 OP0161 https://t.co/osaORtgvxh https://t.co/96PypMtlcl
      RT @ericdeinmd: #EULAR2022 OP0138:
      BIOBADASER registry:
      Cancer risk in AI disease after bDMARD & tsDMARD + h/o prior

      Eric Dein ericdeinmd

      3 years 6 months ago
      #EULAR2022 OP0138: BIOBADASER registry: Cancer risk in AI disease after bDMARD & tsDMARD + h/o prior malignancy ⭐️352 pts w prior malignancy in registry, 32 developed a 2nd incident malignancy 27 rate of cancer/1000 patient years. No diff of cancer or mortality b/w Rx @Rheumnow https://t.co/nTuUooBmzV
      RT @RichardPAConway: Ghalandari et al EUDRAVIGILANCE database congenital malformations for non-TNFi bDMARDs (vs certoliz

      Richard Conway RichardPAConway

      3 years 6 months ago
      Ghalandari et al EUDRAVIGILANCE database congenital malformations for non-TNFi bDMARDs (vs certolizumab). ORs suggest possible B-cell modulators and vedolizumab, not others. Geneticist rvw no pattern for B-cell agents. @RheumNow #EULAR2022 OP0129 https://t.co/nrj8MxjAri https://t.co/p6JkfjjtdH
      RT @KDAO2011: Interestingly, anti-IFN Ab can be present in #SLE pts and impact the IFN signature.

      There is a bimodal t

      TheDaoIndex KDAO2011

      3 years 6 months ago
      Interestingly, anti-IFN Ab can be present in #SLE pts and impact the IFN signature. There is a bimodal type I IFN signature in #SLE. IFN and Blys signatures overlap (?distinct populations/interactions between the two?) - Prof T Dorner #EULAR2022 @rheumnow https://t.co/phLXv2KVxR
      RT @AurelieRheumo: All the domains of sexual sphere are deteriorated in RA and PsA.
      This aspect is often overlooked and

      Aurelie Najm AurelieRheumo

      3 years 6 months ago
      All the domains of sexual sphere are deteriorated in RA and PsA. This aspect is often overlooked and can have a significant impact on pts QoL. It may be time to assess this aspect more specifically using CSFQ-14 and propose dedicated interventions. #OP0139 @RheumNow #EULAR2022 https://t.co/l0zyBIZ1LI
      RT @RichardPAConway: Dr Puja Khanna. Transdermal sodium bicarbonate for gout flare. WHAT!? It works as well! Double-blin

      Richard Conway RichardPAConway

      3 years 6 months ago
      Dr Puja Khanna. Transdermal sodium bicarbonate for gout flare. WHAT!? It works as well! Double-blind RCT. All got colchicine also. Response rate 95% vs 79%. Resolution in 24 vs 72 hrs. Rescue meds 6% vs 20%. No adverse events! @RheumNow #EULAR2022 OP0170 https://t.co/INd4tMFVlV https://t.co/EyVjFLF72z
      RT @ericdeinmd: #EULAR2022 ASAS/EULAR AxSpA Recs
      ⭐️Last: 2016
      ▶️All: education, exercise, 🚭
      ▶️❌csDMARD

      Eric Dein ericdeinmd

      3 years 6 months ago
      #EULAR2022 ASAS/EULAR AxSpA Recs ⭐️Last: 2016 ▶️All: education, exercise, 🚭 ▶️❌csDMARD for axial disease ▶️TNF/IL17 (or JAK) with high disease: ASDAS>/=2.1 ▶️Monoclonal TNF for uveitis/IBD, high PsO: IL-17 ▶️Sustained remission: tapering of bDMARD "can be considered" @RheumNow https://t.co/3yYU0Vb37r
      RT @KDAO2011: Proof that MTX doesn't affect sperm! Sperm morphology, motility, concentration, semen volume, testosterone

      TheDaoIndex KDAO2011

      3 years 6 months ago
      Proof that MTX doesn't affect sperm! Sperm morphology, motility, concentration, semen volume, testosterone/LH/FSH similar b/f and after exposure; DNA fragmentat'n was⬆️in pre-MTX exposure (possible reason high dz activity contributes to infertility) #EULAR2022 @rheumnow OP0131 https://t.co/JWLEggRhAY
      RT @RichardPAConway: Hamroun @annamolto et al. Factors assoc with increased time to conception in SpA. 56 pregnancies. M

      Richard Conway RichardPAConway

      3 years 6 months ago
      Hamroun @annamolto et al. Factors assoc with increased time to conception in SpA. 56 pregnancies. Multivariate model, age (HR 1.22 (1.08-1.40)) and preconception NSAID use (HR 3.01 (2.15-3.85)) assoc increase time to conception. @RheumNow #EULAR2022 OP0153 https://t.co/y2EAyAdRmk https://t.co/28aLimRInE
      RT @KDAO2011: OP0129 Eudravigilance eval pregnancies exposed to non-TNF biologics compared certolizumab. Possible signal

      TheDaoIndex KDAO2011

      3 years 6 months ago
      OP0129 Eudravigilance eval pregnancies exposed to non-TNF biologics compared certolizumab. Possible signal w/#vendolizumab: 3 cases of corpus callosum agenesis (2 Crohn’s, 1 UC, 2 assc w/ other CNS malformations). Belim did not show consistent pattern #EULAR2022 @rheumnow https://t.co/BNKaxu6G0c
      RT @RichardPAConway: Perez-Garcia et al. MTX effect on semen parameters. I still frequently get queries about this. 48 p

      Richard Conway RichardPAConway

      3 years 6 months ago
      Perez-Garcia et al. MTX effect on semen parameters. I still frequently get queries about this. 48 participants here. No significant effect! @RheumNow #EULAR2022 OP0131 https://t.co/33NG6isehm https://t.co/g7Xn33i96u
      RT @Yuz6Yusof: #OP0142 #EULAR2022 Morand compared LLDAS in Early (<1yr) and Established #lupus. Although Early were

      Md Yuzaiful Md Yusof Yuz6Yusof

      3 years 6 months ago
      #OP0142 #EULAR2022 Morand compared LLDAS in Early (<1yr) and Established #lupus. Although Early were younger & had higher disease activity, time-to-LLDAS was shorter. LLDAS was protective of flare in both. Should target for LLDAS early in diagnosis to improve outcomes @RheumNow https://t.co/7i9c69YkR3
      RT @KDAO2011: In people without SLE who have severe COVID19 infection, autoAb against IFN-1 assc w/increased mortality P

      TheDaoIndex KDAO2011

      3 years 6 months ago
      In people without SLE who have severe COVID19 infection, autoAb against IFN-1 assc w/increased mortality Prof T Dorner #EULAR2022 @rheumnow https://t.co/nt2gACUtkL
      RT @RichardPAConway: BIOBADASER Registry data on comparative drug-dependent cancer risk in patients with prior cancer. 3

      Richard Conway RichardPAConway

      3 years 6 months ago
      BIOBADASER Registry data on comparative drug-dependent cancer risk in patients with prior cancer. 352 patients. 32 incident cancers (14 NMSC). No difference between agents, but wide CIs @RheumNow #EULAR2022 OP0138 https://t.co/NEZSL2AQhC https://t.co/EG0NflXXW6

      Podcasts

      • CD19 CAR T Cell Therapy In SLE (9.16.2022) 00:19:20
      • Does Fibromyalgia Need B12 00:27:04
      • StillsNow Podcast August 2022 - Genetic Testing for Autoinflammatory Diseases 00:28:27

      Catch up on Conference Podcasts

      ×